Financial Ratios | JB Chemicals & Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY14909.70  -187.65 (-1.24%)
SENSEX50261.87  -777.44 (-1.52%)
  • top gainers
  • top losers
  • top volume
  • top value
  • indian indices
  • global indices

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE1135.00-3.95 (-0.35 %)
PREV CLOSE (Rs.) 1138.95
OPEN PRICE (Rs.) 1138.95
BID PRICE (QTY) 1133.05 (8)
OFFER PRICE (QTY) 1135.75 (4)
VOLUME 1412
TODAY'S LOW / HIGH (Rs.)1106.60 1143.00
52 WK LOW / HIGH (Rs.)434.9 1262.95
NSE1140.051.6 (+0.14 %)
PREV CLOSE( Rs. ) 1138.45
OPEN PRICE (Rs.) 1130.00
BID PRICE (QTY) 1140.05 (100)
OFFER PRICE (QTY) 1140.90 (22)
VOLUME 18152
TODAY'S LOW / HIGH(Rs.) 1107.05 1143.35
52 WK LOW / HIGH (Rs.)415 1263

Financial Ratios

Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Operational & Financial Ratios
   Earnings Per Share (Rs)35.2024.1116.5521.7019.16
   CEPS(Rs)43.8331.1123.4227.3123.87
   DPS(Rs)11.005.002.001.005.00
   Book NAV/Share(Rs)185.75184.47172.50160.77139.57
   Tax Rate(%)21.9332.4128.4819.8123.52
Margin Ratios
   Core EBITDA Margin(%)21.2818.6114.0916.9816.73
   EBIT Margin(%)19.8417.7513.9717.2017.98
   Pre Tax Margin(%)19.6617.4713.7216.8017.12
   PAT Margin (%)15.3511.809.8113.4813.09
   Cash Profit Margin (%)19.0915.1913.8416.9316.44
Performance Ratios
   ROA(%)12.548.526.438.999.21
   ROE(%)18.6913.289.8914.4814.80
   ROCE(%)23.6919.5913.7016.8717.72
   Asset Turnover(x)0.820.720.660.670.70
   Sales/Fixed Asset(x)1.571.541.351.531.82
   Working Capital/Sales(x)2.342.041.832.663.20
Efficiency Ratios
   Fixed Capital/Sales(x)0.640.650.740.650.55
   Receivable days67.2267.6373.1571.8479.28
   Inventory Days53.3150.8153.4351.7750.12
   Payable days32.7432.2133.6632.8632.45
Valuation Parameters
   PER(x)14.4414.9118.6815.9913.01
   PCE(x)11.6011.5613.2012.7110.45
   Price/Book(x)2.741.951.792.161.79
   Yield(%)2.161.390.650.292.00
   EV/Net Sales(x)2.211.751.832.181.86
   EV/Core EBITDA(x)9.178.2810.1510.548.74
   EV/EBIT(x)11.169.8613.0812.6610.37
   EV/CE(x)1.951.231.161.431.14
   M Cap / Sales2.211.761.832.151.72
Growth Ratio
   Net Sales Growth(%)8.0016.233.3211.107.64
   Core EBITDA Growth(%)23.3836.50-9.957.5637.52
   EBIT Growth(%)20.7547.71-16.096.2645.34
   PAT Growth(%)40.4339.83-24.7714.3760.59
   EPS Growth(%)45.9945.66-23.7213.2461.87
Financial Stability Ratios
   Total Debt/Equity(x)0.020.020.020.040.16
   Current Ratio(x)2.472.032.051.741.48
   Quick Ratio(x)1.941.721.761.451.25
   Interest Cover(x)108.0962.7456.5443.8120.80
   Total Debt/Mcap(x)0.010.010.010.020.09